Yoshihiro Morita

Dr. Yoshihiro Morita

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YMYuka Matsumiya-Matsumoto
Yuka Matsumiya-Matsumoto
YMYoshihiro Morita
Yoshihiro Morita
NUNarikazu Uzawa
Narikazu Uzawa
Pleomorphic adenoma (PA) is a localized tumor that presents pleomorphic or mixed characteristics of epithelial origin and is interwoven with mucoid tissue, myxoid tissue, and chondroid masses. The literature reported that PA most often occurs in adults aged 30–60 years and is a female predilection; the exact etiology remains unclear. Epithelial–mesenchymal transition (EMT) is the transdifferentiation of stationary epithelial cells primarily activated by a core set of transcription factors (EMT-TFs) involved in DNA repair and offers advantages under various stress conditions. Data have suggested that EMTs represent the basic principle of tissue heterogeneity in PAs, demonstrating the potential of adult epithelial cells to transdifferentiate into mesenchymal cells. It has also been reported that multiple TFs, such as TWIST and SLUG, are involved in EMT in PA and that SLUG could play an essential role in the transition from myoepithelial to mesenchymal cells. Given this background, this review aims to summarize and clarify the involvement of EMT in the development of PA, chondrocyte differentiation, and malignant transformation to contribute to the fundamental elucidation of the mechanisms underlying EMT.

1 April 2014 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
YMYoshihiro Morita
Yoshihiro Morita
NMNobuo Morita
Nobuo Morita
KHKenji Hata
Kenji Hata
MNMasako Nakanishi
Masako Nakanishi
NKNatsuko Kimoto
Natsuko Kimoto
TYToshiyuki Yoneda
Toshiyuki Yoneda

12 March 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
YMYoshihiro Morita
Yoshihiro Morita
KKKana Kashima
Kana Kashima
MSMao Suzuki
Mao Suzuki
HKHiroko Kinosada
Hiroko Kinosada
ATAkari Teramoto
Akari Teramoto
NUNarikazu Uzawa
Narikazu Uzawa
Renal cell carcinoma, which has clear cells in 70% of cases, has a high frequency of hematogenous distant metastases to lung, bone, liver, and other areas. Metastatic cancer accounts for 1 to 3% of malignant tumors in the stomatognathic region, and the metastasis of renal cell carcinoma to the oral mucosal tissue, though extremely rare, does occur. In addition, clear cells have been observed in some salivary gland cancers in the oral cavity. Therefore, the differential diagnosis of metastatic renal cell carcinoma and salivary gland cancer is important. This review discusses the differential diagnosis between metastatic renal cell carcinoma and malignant tumors of the salivary gland.

22 September 2008 in Synfacts
Verified
Journal Article
Closed access
PDF file
YNYun Hau Ng
Yun Hau Ng
SIS. Ikeda
S. Ikeda
THT. Harada
T. Harada
YMYoshihiro Morita
Yoshihiro Morita
MMM. Matsumura
M. Matsumura
Platinum nanoparticles embedded in the porous wall of a hollow carbon shell (nPt@hC) catalyzed the aerobic oxidation of primary and secondary alcohols in water to afford the corresponding carbonyl products with 42-99% conversion (5 examples). In the oxidation of 1-phenylethanol, the catalyst was reused twice without significant loss of catalytic activity (76% conversions for 1st and 2nd reuse runs).

19 March 2020 in Cancers
Verified
Journal Article
Open access
PDF file
YMYoshihiro Morita
Yoshihiro Morita
MLMacall Leslie
Macall Leslie
HKHiroyasu Kameyama
Hiroyasu Kameyama
GLGanesh L. R. Lokesh
Ganesh L. R. Lokesh
NINorihisa Ichimura
Norihisa Ichimura
TTTakemi Tanaka
Takemi Tanaka
Chemotherapy is a mainstay of treatment for solid tumors. However, little is known about how therapy-induced immune cell infiltration may affect therapy response. We found substantial CD45+ immune cell density adjacent to E-selectin expressing inflamed vessels in doxorubicin (DOX)-treated residual human breast tumors. While CD45 level was significantly elevated in DOX-treated wildtype mice, it remained unchanged in DOX-treated tumors from E-selectin null mice. Similarly, intravenous administration of anti-E-selectin aptamer (ESTA) resulted in a significant reduction in CD45+ immune cell density in DOX-treated residual tumors, which coincided with a delay in tumor growth and lung metastasis in MMTV-pyMT mice. Additionally, both tumor infiltrating T-lymphocytes and tumor associated-macrophages were skewed towards TH2 in DOX-treated residual breast tumors; however, ESTA suppressed these changes. This study suggests that DOX treatment instigates de novo intratumoral infiltration of immune cells through E-selectin, and functional blockade of E-selectin may reduce residual tumor burden as well as metastasis through suppression of TH2 shift.

10 August 2024 in Clinical & Experimental Metastasis
Verified
Journal Article
Open access
PDF file
ATAyano Tobe-Nishimoto
Ayano Tobe-Nishimoto
YMYoshihiro Morita
Yoshihiro Morita
JNJunya Nishimura
Junya Nishimura
YKYukiko Kitahira
Yukiko Kitahira
STShun Takayama
Shun Takayama
NUNarikazu Uzawa
Narikazu Uzawa
The process of cervical lymph node metastasis is dependent on the phenotype of the tumor cells and their interaction with the host microenvironment and immune system; conventional research methods that focus exclusively on tumor cells are limited in their ability to elucidate the metastatic mechanism. In cancer tissues, a specialized environment called the tumor microenvironment (TME) is established around tumor cells, and inflammation in the TME has been reported to be closely associated with the development and progression of many types of cancer and with the response to anticancer therapy. In this study, to elucidate the mechanism of metastasis establishment, including the TME, in the cervical lymph node metastasis of oral cancer, we established a mouse-derived oral squamous cell carcinoma cervical lymph node highly metastatic cell line and generated a syngeneic orthotopic transplantation mouse model. In the established highly metastatic cells, epithelial-mesenchymal transition (EMT) induction was enhanced compared to that in parental cells. In the syngeneic mouse model, lymph node metastasis was observed more frequently in tumors of highly metastatic cells than in parental cells, and Cyclooxygenase-2 (COX-2) expression and lymphatic vessels in primary tumor tissues were increased, suggesting that this model is highly useful. Moreover, in the established highly metastatic cells, EMT induction was enhanced compared to that in the parent cell line, and CCL5 and IL-6 secreted during inflammation further enhanced EMT induction in cancer cells. This suggests the possibility of a synergistic effect between EMT induction and inflammation. This model, which allows for the use of two types of cells with different metastatic and tumor growth potentials, is very useful for oral cancer research involving the interaction between cancer cells and the TME in tumor tissues and for further searching for new therapeutic agents.